Prevention. Aspirin in primary prevention--good news and bad news
- PMID: 22371106
- DOI: 10.1038/nrcardio.2012.26
Prevention. Aspirin in primary prevention--good news and bad news
Abstract
The balance of benefits and risks of aspirin in primary prevention is far less clear than in secondary prevention; further data from randomized trials of individuals at intermediate cardiovascular risk are needed. Decisions about aspirin in primary prevention should be made on a case-by-case basis, and general guidelines are not justified.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
